Use of Osteopathic Principles for Nonpharmacologic, Therapeutic Interventions in Women With Polycystic Ovary Syndrome
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Other: YogaOther: OMT
- Registration Number
- NCT03383484
- Lead Sponsor
- Diana Speelman, Ph.D.
- Brief Summary
The overall goals of this project are to assess the efficacy of non-pharmacological, complementary therapies to improve outcomes in the treatment of women with polycystic ovary syndrome (PCOS). The studies proposed herein are designed to assess the efficacy of osteopathic manipulative medicine (OMM) in the assessment of sympathetic tone in these women, and the effectiveness of non-pharmacologic therapeutic interventions in improving participant metabolic, endocrine, reproductive, and psychological health.
- Detailed Description
Question 1: Can osteopathic structural assessment identify increased sympathetic tone in women with PCOS? Specific Aim 1: To use palpation of Chapman points and spinal viscerosomatic reflex regions to assess the presence and degree of increased sympathetic tone in women with PCOS.
Chapman points and viscerosomatic reflexes reflect visceral dysfunction and are mediated by the sympathetic nervous system, and can be a very useful clinical diagnostic tool. There is increased sympathetic tone in women with PCOS as well as in obese individuals, as previously determined by physiologic measures. Increased sympathetic tone in the study population will be assessed by osteopathic structural assessment and confirmed by physiologic measures of heart rate, heart rate variability, resting blood pressure, and blood pressure and heart rate recovery following exercise.
Hypothesis: Chapman points will be palpable at regions for the heart, adrenal glands, and ovaries to indicate hyperactivity of the sympathetic nervous system and will correlate with physiologic evidence of increased sympathetic tone.
Hypothesis: Alterations of viscerosomatic reflexes associated with the heart, adrenal glands, and ovaries will reflect hyperactivity of the sympathetic nervous system and will correlate with physiologic evidence of increased sympathetic tone.
Question 2: Can regular, sympathetic nervous system-targeted osteopathic manipulative treatment (OMT) improve endocrine and reproductive parameters, and sympathetic tone, in women with PCOS? Specific Aim 2: To use weekly manipulation of Chapman points and spinal regions associated with viscerosomatic reflexes in women with PCOS for improvement of endocrine and reproductive parameters, and sympathetic tone, after 3 months of treatment.
Chapman points and viscerosomatic reflexes are useful in diagnosis, and may be manipulated to restore somatovisceral health.
Hypothesis: Completion of 3 months of weekly manipulation of Chapman points and viscerosomatic reflexes will improve sympathetic tone (as assessed by both osteopathic structural assessment and physiologic parameters), androgen levels, and menstrual cycle length compared to women with PCOS and no intervention.
Question 3: Can regular yoga improve metabolic, endocrine, reproductive, and psychological parameters in women with PCOS? Specific Aim 3: To use thrice-weekly yoga practice with mindfulness techniques in women with PCOS to improve metabolic, endocrine, reproductive, and psychological parameters after 3 months of intervention.
The benefits of moderate and high-intensity aerobic activity on metabolic and overall health for women with PCOS have been reported, but the effects of low-impact exercise are less studied. Women with PCOS will participate in a yoga class with integrated mindfulness techniques 3 times per week for 3 months.
Hypothesis: Thrice weekly yoga intervention for 3 months will result in an improvement in androgen levels, fasting blood glucose, menstrual cycle length, and patient-reported anxiety, compared to women with PCOS and no intervention.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 45
- Females between the ages of 20-44, with a body mass index (BMI) of 20-48, who had a confirmed diagnosis of PCOS from their provider, and exhibited the 2003 Rotterdam criteria for PCOS diagnosis, defined as at least two out of the following three features: clinical or biochemical hyperandrogenism (moderate acne or a modified Ferriman-Gallwey score > 6 or free testosterone > 5 pg/mL), polycystic ovaries (> 12 cysts on one ovary by ultrasound or ovarian volume > 10 mL for one ovary), and menstrual irregularity (defined as < 8 menstrual periods per year or cycles averaging > 35 days in length).
- Females who were smokers, had used hormone-based medications within the last 3 months (hormonal contraception, ovulation inducers, anti-androgens) or who were on insulin-sensitizing agents, had another endocrine disorder diagnosis, were pregnant or breastfed within the last 6 months, were diagnosed with a major psychiatric disorder or were on anti-psychotic medication, or who were currently practicing yoga or receiving osteopathic manipulative treatment or acupuncture on a regular basis.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Yoga intervention Yoga Yoga 3 times per week for 3 months OMT intervention OMT Weekly OMT for 3 months
- Primary Outcome Measures
Name Time Method Change in androgens After 3 month intervention (immediately after 3 month intervention) compared with pre intervention (initial = 0 months) Change in serum androgen levels with intervention
- Secondary Outcome Measures
Name Time Method Change in menstrual cycle length After 3 month intervention (immediately after 3 month intervention) compared with pre intervention (initial = 0 months) Change in average time between day 1 of consecutive menstrual cycles after intervention
Change in acne After 3 month intervention (immediately after 3 month intervention) compared with pre intervention (initial = 0 months) Acne score after intervention (none, mild, moderate, severe)
Change in BMI After 3 month intervention (immediately after 3 month intervention) compared with pre intervention (initial = 0 months) BMI value after intervention
Change in waist:hip ratio After 3 month intervention (immediately after 3 month intervention) compared with pre intervention (initial = 0 months) Waist:hip ratio after intervention
Change in fasting blood glucose After 3 month intervention (immediately after 3 month intervention) compared with pre intervention (initial = 0 months) Serum glucose levels after intervention
Change in fasting insulin After 3 month intervention (immediately after 3 month intervention) compared with pre intervention (initial = 0 months) Serum insulin levels after intervention
Change in depression score After 3 month intervention (immediately after 3 month intervention) compared with pre intervention (initial = 0 months) Beck Depression Index II score after intervention (total score 0 to 63, lower score means better outcome)
Change in anxiety After 3 month intervention (immediately after 3 month intervention) compared with pre intervention (initial = 0 months) Beck Anxiety index score after intervention (total score 0 to 63, lower score means better outcome)
Change in blood pressure After 3 month intervention (immediately after 3 month intervention) compared with pre intervention (initial = 0 months) Blood pressure after intervention
Change in heart rate recovery After 3 month intervention (immediately after 3 month intervention) compared with pre intervention (initial = 0 months) Heart rate recovery from exercise after intervention
Change in heart rate variability After 3 month intervention (immediately after 3 month intervention) compared with pre intervention (initial = 0 months) Heart rate variability measured by EKG after intervention